Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS), ISIN INE09XN01023 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AKUMS last traded at ₹824.50 (+0.10%), with a 52-week range of ₹410.10 to ₹839.25 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 75.26%, FIIs 1.91%, DIIs 13.44%, mutual funds 9.77%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.